INS and type 2 diabetes mellitus: In total, 6 patients had type 2 diabetes with a good glycemic control (HbA1c < 7.5%); of these, one was treated only with metformin, two with metformin plus DPPIV inhibitor plus insulin secretagogue, and three with metformin plus DPPIV inhibitor plus insulin.